From preeclampsia to eclampsia: a physiopathological approach;De la toxémie gravidique à l'éclampsie : physiopathologie

Reanimation

Volumn 16, Issue 5, 2007, Pages 380-385

  Meziani, F ^a,b   Tesse, A ^b   Asfar, P ^a   Schneider, F ^c   Andriantsitohaina, R ^b   Fournie, A ^a   Gairard, A ^d  

^a ANGERS UNIVERSITY HOSPITAL   (France)

^b Universite d'Angers   (France)

^c HÔPITAL DE HAUTEPIERRE   (France)

^d CNRS   (France)

Author keywords

Angiogenesis; Hypertension; Inflammation; Microparticles; Preeclampsia; Pregnancy

Indexed keywords

REACTIVE OXYGEN METABOLITE;

ANGIOGENESIS; BLOOD VESSEL INJURY; CELL ACTIVATION; ECLAMPSIA; ENDOTHELIAL DYSFUNCTION; FETOMATERNAL TRANSFUSION; FETUS GROWTH; GENE EXPRESSION; HUMAN; HYPERTENSION; HYPOXIA; IMMUNITY; INFLAMMATION; LEUKOCYTE; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PLACENTA DEVELOPMENT; PREECLAMPSIA; SHORT SURVEY; THROMBOCYTE;

EID: 34548680316     PISSN: 16240693     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.reaurg.2007.07.005     Document Type: Short Survey

References (43)

1. Redman C.W. Current topic: pre-eclampsia and the placenta. Placenta 12 (1991) 301-308
2. Davison J.M., Homuth V., Jeyabalan A., Conrad K.P., Karumanchi S.A., Quaggin S., et al. New aspects in the pathophysiology of preeclampsia. J. Am. Soc. Nephrol. 15 9 (2004) 2440-2448
3. Widmer M., Villar J., Benigni A., Conde-Agudelo A., Karumanchi S.A., and Lindheimer M. Mapping the theories of preeclampsia and the role of angiogenic factors: a systematic review. Obstet. Gynecol. 109 1 (2007) 168-180
4. Redman C.W., and Sargent I.L. Preeclampsia and the systemic inflammatory response. Semin. Nephrol. 24 6 (2004) 565-570
5. Fischer T., Schneider M.P., Schobel H.P., Heusser K., Langenfeld M., and Schmieder R.E. Vascular reactivity in patients with preeclampsia and HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome. Am. J. Obstet. Gynecol. 183 6 (2000) 1489-1494
6. Sibai B., Dekker G., and Kupferminc M. Pre-eclampsia. Lancet 365 (2005) 785-799
7. Raijmakers M.T., Dechend R., and Poston L. Oxidative stress and preeclampsia: rationale for antioxidant clinical trials. Hypertension 44 4 (2004) 374-380
8. Lindheimer M.D., and Sibai B.M. Antioxydant supplementation in preeclampsia. Lancet 367 9517 (2006) 1119-1120
9. Shah D.M. Preeclampsia: new insights. Curr. Opin. Nephrol. Hypertens. 16 3 (2007) 213-220
10. Sibai B., Dekker G., and Kupferminc M. Pre-eclampsia. Lancet 365 (2005) 785-799
11. Goldenberg R.L., and Rouse D.J. Prevention of premature birth. N. Engl. J. Med. 339 5 (1998) 313-320
12. National High Blood Pressure Education Program Working Group on High Pressure in Pregnancy. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am. J. Obstet. Gynecol. 183 (2000) S1-S22
13. Moodley J., and Kalane G. A review of the management of eclampsia: practical issues. Hypertens. Pregnancy 25 2 (2006) 47-62
14. Stennett A.K., and Khalil R.A. Neurovascular mechanisms of hypertension in pregnancy. Curr Neurovasc Res. 3 2 (2006) 131-148
15. Milne F., Redman C., Walker J., Baker P., Bradley J., Cooper C., et al. The preeclampsia community guideline (PRECOG): how to screen for and detect onset of pre-eclampsia in the community. BMJ 330 7491 (2005) 576-580
16. Duckitt K., and Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ 330 7491 (2005) 565-571
17. Moffett-King A. Natural killer cells and pregnancy. Nat. Rev. Immunol. 2 (2002) 656-663
18. King A., Burrows T.D., Hiby S.E., Joseph S., Verma S., Lim P.B., et al. Surface expression of HLA-C antigen by human extravillous trophoblast. Placenta 21 (2000) 376-387
19. Vilches C., and Parham P. KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. Annu. Rev. Immunol. 20 (2002) 217-251
20. Sargent I.L., Borzychowski A.M., and Redman C.W. NK cells and pre-eclampsia. J. Reprod. Immunol. (2007) (in press)
21. Moffett A., and Loke Y.W. The immunological paradox of pregnancy: a reappraisal. Placenta 25 1 (2004) 1-8
22. Ramsey E.M., Corner G.W., Donner M.W., and Stran H.M. Radioangiographic studies of circulation in the maternal placenta of the rhesus monkey: preliminary report. Proc. Natl. Acad. Sci. USA 46 (1960) 1003-1008
23. Borzychowski A.M., Sargent I.L., and Redman C.W. Inflammation and pre-eclampsia. Semin. Fetal Neonatal Med. 11 5 (2006) 309-316
24. Noris M., Perico N., and Remuzzi G. Mechanisms of disease: Pre-eclampsia. Nat Clin Pract Nephrol. 1 2 (2005) 98-114
25. Burton G.J., and Jauniaux E. Placental oxidative stress: from miscarriage to preeclampsia. J. Soc. Gynecol. Investig. 11 6 (2004) 342-352
26. Roberts J.M., Pearson G., Cutler J., Lindheimer M., and Working N.H.L.B.I. Group on Research on Hypertension During Pregnancy. Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy. Hypertension 41 3 (2003) 437-445
27. Oudejans C.B., van Dijk M., Oosterkamp M., Lachmeijer A., and Blankenstein M.A. Genetics of preeclampsia: paradigm shifts. Hum. Genet. 120 5 (2007) 607-612
28. Seely E.W., and Solomon C.G. Insulin resistance and its potential role in pregnancy-induced hypertension. J. Clin. Endocrinol. Metab. 88 6 (2003) 2393-2398
29. Barden A.E., Beilin L.J., Ritchie J., Walters B.N., and Michael C. Does a predisposition to the metabolic syndrome sensitize women to develop pre-eclampsia?. J. Hypertens. 17 9 (1999) 1307-1315
30. Roberts J.M., Taylor R.N., Musci T.J., Rodgers G.M., Hubel C.A., and McLaughlin M.K. Preeclampsia: an endothelial cell disorder. Am. J. Obstet. Gynecol. 161 (1989) 1200-1204
31. Shah T.J., and Walsh S.W. Activation of NF-κB and expression of COX-2 in association with neutrophil infiltration in systemic vascular tissue of women with preeclampsia. Am. J. Obstet. Gynecol. 196 1 (2007) 48 (e1-8)
32. Sakawi Y., Tarpey M., Chen Y.F., Calhoun D.A., Connor M.G., Chestnut D.H., et al. Evaluation of low-dose endotoxin administration during pregnancy as a model of preeclampsia. Anesthesiology 93 6 (2000) 1446-1455
33. Redman C.W., and Sargent I.L. Preeclampsia, the placenta and the maternal systemic inflammatory response--a review. Placenta 24 Suppl A (2003) S21-S27
34. Crews J.K., Herrington J.N., Granger J.P., and Khalil R.A. Decreased endothelium-dependent vascular relaxation during reduction of uterine perfusion pressure in pregnant rat. Hypertension 35 1 Pt 2 (2000) 367-372
35. Suzuki Y., Hattori T., Kajikuri J., Yamamoto T., Suzumori K., and Itoh T. Reduced function of endothelial prostacyclin in human omental resistance arteries in preeclampsia. J. Physiol. 545 Pt 1 (2002) 269-277
36. Roberts J.M., and Hubel C.A. Oxidative stress in preeclampsia. Am. J. Obstet. Gynecol. 190 5 (2004) 1177-1178
37. Walsh S.W., Vaughan J.E., Wang Y., and Roberts L.J. Placental isoprostane is significantly increased in preeclampsia. FASEB J. 14 10 (2000) 1289-1296
38. Levine R.J., Maynard S.E., Qian C., Lim K.H., England L.J., Yu K.F., et al. Circulating angiogenic factors and the risk of preeclampsia. N. Engl. J. Med. 350 7 (2004) 672-683
39. Venkatesha S., Toporsian M., Lam C., Hanai J., Mammoto T., Kim Y.M., et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat. Med. 12 6 (2006) 642-649
40. Sibai B.M. Imitators of severe preeclampsia. Obstet. Gynecol. 109 4 (2007) 956-966
41. Redman C.W., and Sargent I.L. Microparticles and immunomodulation in pregnancy and pre-eclampsia. J. Reprod. Immunol. (2007) (in press)
42. Bretelle F., Sabatier F., Desprez D., Camoin L., Grunebaum L., Combes V., et al. Circulating microparticles: a marker of procoagulant state in normal pregnancy and pregnancy complicated by preeclampsia or intrauterine growth restriction. Thromb. Haemost. 89 3 (2003) 486-492
43. Meziani F., Tesse A., David E., Martinez M.C., Wangesteen R., Schneider F., et al. Shed membrane particles from preeclamptic women generate vascular wall inflammation and blunt vascular contractility. Am. J. Pathol. 169 4 (2006) 1473-1483